Ken Romeril
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Multiple Myeloma Research and Treatments 6
- Genetics 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Chronic Lymphocytic Leukemia Research 2
- Blood disorders and treatments 1
- Co-authors
- Alan J. Concannon (1 shared paper)David C. Heaton (2 shared papers)Evan A. Jolliffe (1 shared paper)Peter S. Ganly (1 shared paper)Jack Le Vance (1 shared paper)Jackson (1 shared paper)Peter E. Hollings (1 shared paper)Stephen J. Grant (1 shared paper)
- Journals
- The Medical Journal of Australia (2 papers)American Journal of Hematology (2 papers)Journal of Clinical Oncology (1 paper)Leukemia (1 paper)The Lancet (1 paper)
- Partner nations
- New ZealandAustraliaBelgium
In The Last Decade
Ken Romeril
15 papers receiving 353 citations
Peers
Comparison fields: 5 of 60
- Hematology 238
- Genetics 49
- Oncology 99
- Transplantation 8
- Emergency Medicine 18
Countries citing papers authored by Ken Romeril
This map shows the geographic impact of Ken Romeril's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Romeril with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Romeril more than expected).
Fields of papers citing papers by Ken Romeril
This network shows the impact of papers produced by Ken Romeril. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Romeril. The network helps show where Ken Romeril may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Romeril, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 153 | |
| 2 | 2016 | 72 | |
| 3 | 2011 | 34 | |
| 4 | 1981 | 29 | |
| 5 | Heparin induced thrombocytopenia: case reports and a prospective study. | 1982 | 13 |
| 6 | Severe trimethoprim induced neutropenia and thrombocytopenia. | 1993 | 11 |
| 7 | Hepatitis C seroprevalence in bone marrow transplant recipients and haemophiliacs. | 1994 | 10 |
| 8 | 2006 | 10 | |
| 9 | Investigation of subjects with abnormal iron studies: role of the hepatic iron index. | 1994 | 8 |
| 10 | 2014 | 7 | |
| 11 | 1981 | 6 | |
| 12 | 1995 | 6 | |
| 13 | 2015 | 5 | |
| 14 | Treatment of hairy cell leukaemia with recombinant alpha interferon. | 1989 | 3 |
| 15 | 1996 | 1 | |
| 16 | Consensus statement on the treatment of transplant-eligible patients with newly diagnosed multiple myeloma in New Zealand. | 2020 | 0 |
| 17 | 2021 | 0 |
About Ken Romeril
Ken Romeril is a scholar working on Hematology, Genetics, Oncology, Emergency Medicine and Molecular Biology, having authored 17 papers that have together received 368 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Protein Degradation and Inhibitors (3 papers), Cancer Treatment and Pharmacology (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Hematological disorders and diagnostics (2 papers) and Blood disorders and treatments (1 paper). The work is most often cited by research in Hematology (238 citations), Genetics (49 citations), Oncology (99 citations), Transplantation (8 citations) and Emergency Medicine (18 citations). Ken Romeril has collaborated with scholars based in New Zealand, Australia and Belgium. Frequent co-authors include Alan J. Concannon, David C. Heaton, Evan A. Jolliffe, Peter S. Ganly, Jack Le Vance, Jackson, Peter E. Hollings, Stephen J. Grant, Peter Myles George and BRUCE A. CHAPMAN. Their work appears in journals such as The Medical Journal of Australia, American Journal of Hematology, Journal of Clinical Oncology, Leukemia and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.